Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Childhood Antibiotic Use Could Lead to Increased Risks of Asthma, Allergies, Other Conditions: Study Researchers warn that multiple rounds of antibiotics before the age of 2 may increase the risks of chronic respiratory issues and food sensitivities. April 28, 2025 Martha Garcia Add Your Comments Amid continuing concerns about the widespread overuse of antibiotics, which is known to increase the risk of dangerous antibiotic resistant infections, new research suggests that early exposure to the drugs may also disrupt a child’s microbiome enough to cause a number of different types of chronic conditions. According to findings published in The Journal of Infectious Diseases on April 16, children exposed to antibiotics before the age of 2 years old had a higher likelihood they would develop asthma, hay fever and food allergies. Antibiotics are often used during early childhood to treat conditions such as ear infections and pneumonia. Some infants can experience chronic ear infections until their inner ear tube grows, preventing recurrent infections. This makes them more likely to be exposed to multiple rounds of antibiotics before the age of 2. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Researchers from the Center for Pharmacoepidemiology and Treatment Science at Rutgers Institute for Health studied nearly 1.1 million children using data from electronic health records from the United Kingdom from 1987 to 2020. Children involved in the study were exposed to antibiotics from birth to age 2 years old. The research team, led by Dr. Daniel Horton, analyzed diagnoses of chronic pediatric conditions through the age of 12. The data indicates antibiotic use before the age of 2 was linked with an increased risk of asthma, food allergies, intellectual disability and hay fever. The researchers noted strong links were observed for those conditions if the participants had multiple antibiotic courses during their early childhood. However, the risk of developing autoimmune conditions and psychiatric conditions were low. The same findings were noted for siblings who had different experiences with antibiotics. The research team concluded that early childhood exposure to antibiotics was dose-dependent with intellectual disability but not celiac disease, inflammatory bowel disease, juvenile idiopathic arthritis, psoriasis, type 1 diabetes, attention-deficit hyperactivity disorder (ADHD), autism spectrum disorders and anxiety. Antibiotics May Disrupt Children’s Gut Microbiome Researchers warn that chronic exposure to antibiotics may disrupt the gut microbiome at a crucial time during a child’s development. Prior research has already highlighted the risks of antibiotic use and overuse in young children as well as unborn fetuses. A study published in 2012 by Danish researchers indicated exposure to antibiotics during pregnancy increased the risk of asthma during childhood. The link was especially true for infants exposed to antibiotics during the third trimester of pregnancy. Data from a 2015 study, conducted by Johns Hopkins researchers, concluded multiple courses of antibiotics during childhood may increase a child’s risk of gaining weight and becoming obese later in life. In addition, antibiotic overuse during infancy may increase the likelihood vaccinations will not be effective. Infants who received antibiotics before the age of 2 had fewer vaccine antibodies for diphtheria-tetanus-acellular pertussis (DTaP) and pneumococcal conjugate (PCV) vaccines. Hospital data indicates children are more likely to receive antibiotics for pneumonia when they are treated in emergency rooms, where they are often given antibiotics even without confirmed diagnoses. Children are also often given double rounds of antibiotics when they are first seen in the ER and later when they are discharged from the hospital, indicating children are receiving far more courses of antibiotics than necessary. Find Out If You Qualify for Infant Formula NEC Compensation Tags: Allergies, Antibiotics, Asthma, Children, Developmental Disorders, Gut, Hay Fever Written By: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. More Baby Formula Stories Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025 Similac Lawsuit Claims Infant Formula Side Effects Led to Preemie’s Death October 27, 2025 Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025
Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)